These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26587772)

  • 21. Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction.
    Chao TH; Lin TC; Shieh Y; Chang TY; Hung KL; Liu CH; Lee TH; Chang YJ; Lee JD; Chang CH
    Eur Neurol; 2013; 70(5-6):316-21. PubMed ID: 24080988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update.
    Derex L; Nighoghossian N
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1093-9. PubMed ID: 18223014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors for Intracranial Hemorrhage Following Intravenous Thrombolysis in Posterior Circulation Stroke.
    Dorňák T; Král M; Sedláčková Z; Šaňák D; Čecháková E; Divišová P; Zapletalová J; Kaňovský P
    Transl Stroke Res; 2018 Dec; 9(6):582-588. PubMed ID: 29333567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D; Sairanen T; Meretoja A; Pitkäniemi J; Putaala J; Salonen O; Silvennoinen H; Kaste M; Tatlisumak T;
    Neurology; 2011 Jul; 77(4):341-8. PubMed ID: 21715707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis.
    Dorado L; Millán M; Pérez de la Ossa N; Guerrero C; Gomis M; Aleu A; López-Cancio E; Cuadras P; Dávalos A
    Eur J Neurol; 2012 Sep; 19(9):1251-5. PubMed ID: 22568604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Kuliha M; Herzig R; Roubec M; Skoloudík D; Zapletalová J; Köcher M; Král M; Veverka T; Cecháková E; Bártková A; Procházka V; Kaňovský P
    Eur Neurol; 2012; 67(1):52-6. PubMed ID: 22156368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolytic treatment to stroke mimic patients via telestroke.
    Asaithambi G; Castle AL; Sperl MA; Ravichandran J; Gupta A; Ho BM; Hanson SK
    Clin Neurol Neurosurg; 2017 Feb; 153():5-7. PubMed ID: 27992822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after tissue plasminogen activator administration under the drip and ship paradigm may differ according to the regional stroke care system.
    Cha JK; Nah HW; Kang MJ; Kim DH; Park HS; Kim SB; Jeong EH; Huh JT
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):160-3. PubMed ID: 24157090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.
    AbdelRazek MA; Mowla A; Hojnacki D; Zimmer W; Elsadek R; Abdelhamid N; Elsadek L; Farooq S; Kamal H; Crumlish A; Shirani P; Ching M; Sawyer R
    Cerebrovasc Dis; 2015; 40(5-6):201-4. PubMed ID: 26402147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a multivariable prediction model for functional outcome after reperfusion therapy for acute ischaemic stroke: study protocol for the Targeting Optimal Thrombolysis Outcomes (TOTO) multicentre cohort study.
    Holliday E; Lillicrap T; Kleinig T; Choi PMC; Maguire J; Bivard A; Lincz LF; Hamilton-Bruce MA; Rao SR; Snel MF; Trim PJ; Lin L; Parsons MW; Worrall BB; Koblar S; Attia J; Levi C
    BMJ Open; 2020 Apr; 10(4):e038180. PubMed ID: 32265253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous thrombolysis in patients with stroke attributable to small artery occlusion.
    Fluri F; Hatz F; Rutgers MP; Georgiadis D; Sekoranja L; Schwegler G; Sarikaya H; Weder B; Müller F; Lüthy R; Arnold M; Reichhart M; Mattle HP; Tettenborn B; Nedeltchev K; Hungerbühler HJ; Sztajzel R; Baumgartner RW; Michel P; Lyrer PA; Engelter ST
    Eur J Neurol; 2010 Aug; 17(8):1054-60. PubMed ID: 20136649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical Superficial Siderosis and Risk of Bleeding after Thrombolysis for Ischemic Stroke.
    Gattringer T; Eppinger S; Beitzke M; Wuensch G; Niederkorn K; Deutschmann H; Fazekas F; Enzinger C
    Cerebrovasc Dis; 2015; 40(3-4):191-7. PubMed ID: 26351845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage.
    Kellert L; Rocco A; Sykora M; Hacke W; Ringleb PA
    Stroke; 2011 Jun; 42(6):1702-6. PubMed ID: 21527769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic ICH and outcomes in patients after IV tPA: a business of risk or risky business?
    Southerland AM; Malik S; Johnston KC
    Neurology; 2011 Jul; 77(4):315-6. PubMed ID: 21715703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.